ASTM E2526
Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
Available Formats:
- Availability: Immediate Download
- Language: English
- License Type: Single User
- Updates: Not Included
- Availability: Request Quote
- Language: English
- License Type: Enterprise / Multi User
- Updates: Included
About This Item
ASTM E2526 is a focused ASTM standard for evaluating the cytotoxicity of nanoparticulate materials in porcine kidney cells and human hepatocarcinoma cells. It provides a technical framework for assessing how these materials interact with specific cell models, helping users compare results in a more consistent way. For laboratories and organizations working with nanoparticle evaluation, this standard supports more reliable screening and documentation when biological response is a key concern.
What is ASTM E2526?
This standard, ASTM E2526, outlines a test method centered on cytotoxicity evaluation for nanoparticulate materials using porcine kidney cells and human hepatocarcinoma cells. Based on its title, the document is intended to guide testing conditions and interpretation for cell-based assessment of material effects. It is most useful when a repeatable method is needed to evaluate potential cellular toxicity and to support technical comparison across nanoparticle samples.
Where is ASTM E2526 used?
ASTM E2526 is commonly used in laboratory settings that assess nanoparticulate materials before or during product development, quality review, or research screening. It is relevant where cell-based cytotoxicity data are needed to help characterize material behavior and support internal decision-making. The standard may also be used by testing organizations, materials developers, and compliance-focused teams that need a recognized method for evaluating nanoparticle-related biological response.
Why is ASTM E2526 important?
This standard matters because cytotoxicity results can vary significantly without a defined test method. ASTM E2526 helps improve consistency, comparability, and traceability in nanoparticulate materials evaluation. That can reduce uncertainty during product assessment, support quality control, and make procurement or review decisions easier to defend. For teams handling advanced materials, a clear ASTM standard can also help align testing practices with expected technical and documentation requirements.
- Nanoparticulate material cytotoxicity testing
- Porcine kidney cell and human hepatocarcinoma cell models
- Repeatable laboratory evaluation method
- Material screening and comparative assessment
- Technical support for quality and compliance workflows
- Publication Date: 2022-07-21
- Publisher: ASTM
Need This Standard?
Request a personalized quote today to receive the latest edition in PDF or other available formats.
Need This Standard?
Request a personalized quote today to receive the latest edition in PDF or other available formats.
Summarize with AI
Get quick summaries using your favorite AI engine.
Online Standart Disclaimer
OnlineStandart.com is an authorized reseller of international standards through partnerships with authorized distributors. We do not own the copyrights or trademarks of the standards we sell, including but not limited to those of API, ASHRAE, BSI, SAE, ASTM, IEEE, IEC, ASME, ISO, and others.
All product names, logos, and brands are property of their respective owners. All company, product, and service names used on this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.
The content provided on this website is for informational purposes only and is intended to promote our reselling services. OnlineStandart.com is not affiliated with or endorsed by any of the standard organizations unless explicitly stated.